Mental Health Startup Cerebral To Stop ADHD Prescriptions For New Patients
The mental health startup Cerebral said it would stop prescribing controlled substances to treat ADHD for new patients on Wednesday, a week after an ex-executive filed a lawsuit alleging he was fired in retaliation for speaking up about unethical business practices, including the company’s practice of overprescribing stimulants in order to retain patients.
Other Articles in this Edition
A clash over online Adderall prescriptions is raising new questions about telehealth
Adherence to ADHD Meds May Lower Unemployment Risk
Breaking Down the Stigma Surrounding ADHD
Cerebral’s Preferred Pharmacy Truepill Halts Adderall Prescriptions for All Customers
Mental Health Startup Cerebral To Stop ADHD Prescriptions For New Patients
FDA OKs New Nonstimulant Option for Adult ADHD
FDA Approves Xelstrym to Treat ADHD
Autism, ADHD and school absence are risk factors for self-harm, according to new study
Pitt research helps explain how Ritalin sharpens attention
‘Eye-Catching’ Smartphone App Could Make It Easy To Screen for Neurological Disease at Home
Video games could help treat cognitive disorders like depression and ADHD